Biotech startups in the UK got a much-needed capital boost, thanks to Invesco Fund Managers Ltd's USD51 billion purse.
Bio Tech
Bunge Ltd explores options in biofuels investments
Bunge Ltd CEO is seeking to sell off its 'crown jewels' as depressed prices and operating losses have made the business unprofitable.
Zydus signs marketing agreement with Pieris AG
The therapeutic protein molecule Anticalin would be the subject of the an agreement between Zydus and Pieris.
StoneCalibre acquires Anatrace, a unit of Affymetrix
Anatrace was recently acquired by StoneCalibre to expand its portfolio of detergents and lipids for the marketplace.
UK withdraws certification to Wockhardt
Because of the failure to maintain good manufacturing standards, the UK regulatory authorities have withdrawn Wockhardt's certification of good standing.
Latest News
Medtronic Inc and Apollo Hospitals Enterprise formed a joint venture for the development of a low-cost and portable hemodialysis treatment for developing countries.
As reported by Dow Jones, Celesio shares increase after McKesson interest in buyout becomes public. After a report that the McKesson Corp was in discussions with Celesio AG majority shareholder Franz Haniel & Cie GmbH as to a possible buyout, share values of the German drug wholesaler rose to their highest in seventeen years.
Albion Ventures had decided to invest in Aridhia for its cutting edge informatics platform. One of the largest venture capitalists in the United Kingdom, Albion Ventures, had led a substantial investment in health and biomedical informatics company Aridhia Informatics Ltd.
Pharmakea Therapeutics receive funding through Series A round from Bay City Capital and Celgene Corporation.
